Evidence map›Paper›PMID 36937078›Full record

ArticleJournal of experimental pharmacology2023

In vitro Anti-Leishmanial Activities of Methanol Extract of

Tasisa Ketema, Markos Tadele, Zewdie Gebrie, Eyasu Makonnen, Asrat Hailu, Solomon M Abay

Abstract read
In one paragraph

Article in Journal of experimental pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Antileishmanial Activities of Methanol Extract and Solvent Fraction ofAdvances in pharmacological and pharmaceutical sciences · 2025
    Article
  4. Healing and leishmanicidal activity ofFrontiers in chemistry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tasisa KetemaDepartment of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0002-8218-2252
Markos TadeleAnimal Health Research Program, Ethiopian Institute of Agricultural Research, Holetta, Ethiopia.ORCID 0000-0003-4136-4559
Zewdie GebrieDepartment of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia.
Eyasu MakonnenDepartment of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0002-9259-5288
Asrat HailuCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Solomon M AbayDepartment of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0002-7844-3771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Leishmaniasis is one of the neglected tropical diseases, threatening lives of about 350 million people globally. Objective: This study aimed to evaluate Methods: The crude (80% methanol) extract of Results: The crude extract and its hexane, ethyl acetate and butanol fractions showed anti-leishmanial activities, with IC Conclusion: The seeds of the plant possessed anti-leishmanial activities against

Indexed as

amastigoteanti-leishmanial activityBrucea antidysenterica seedsLeishmania aethiopicaLeishmania donovanipromastigote

Identifiers

PMID36937078
PMCPMC10022440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.